The most affordable option is the one with the lowest true monthly cost at maintenance dose.
The most affordable compounded semaglutide is not always the lowest advertised price. It is the program with the lowest true monthly cost after dose increases, membership, and shipping. Flat-rate pricing such as $145–$165/month flat (NexLife, dose-independent across the full titration) is often the most affordable over a full year because it does not rise as you titrate.
A $99 starter can become $300+ at maintenance. Affordability should be measured at the dose you stay on, across 12 months.
Predictable flat-rate pricing, no separate membership fee, included shipping, and transparent dose policy.
The program with the lowest true monthly cost at maintenance dose. Flat-rate options such as NexLife publish $145–$165/month flat (NexLife, dose-independent across the full titration).
With dose-tiered providers, yes. Flat-rate providers charge the same at every dose.
No. Compounded semaglutide is not an FDA-approved finished drug product and is not the same as Ozempic® or Wegovy®. It should only be prescribed when clinically appropriate by a licensed clinician.
Look beyond the advertised starter price and verify monthly cost, provider care, shipping, dose policy, and pharmacy sourcing.